These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22466645)

  • 1. Revertant mosaicism in a human skin fragility disorder results from slipped mispairing and mitotic recombination.
    Kiritsi D; He Y; Pasmooij AM; Onder M; Happle R; Jonkman MF; Bruckner-Tuderman L; Has C
    J Clin Invest; 2012 May; 122(5):1742-6. PubMed ID: 22466645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sporadic Kindler syndrome with a novel mutation.
    Almeida HL; Heckler GT; Fong K; Lai-Cheong J; McGrath J
    An Bras Dermatol; 2013; 88(6 Suppl 1):212-5. PubMed ID: 24346923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel pathogenic FERMT1 variant in four families with Kindler syndrome in Argentina.
    Valinotto LE; Natale MI; Lusso SB; Cella E; Gutiérrez O; Sebastiani F; Manzur GB
    Pediatr Dermatol; 2020 Mar; 37(2):337-341. PubMed ID: 31957900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kindlin-1 Regulates Keratinocyte Electrotaxis.
    Zhang G; Gu Y; Begum R; Chen H; Gao X; McGrath JA; Parsons M; Song B
    J Invest Dermatol; 2016 Nov; 136(11):2229-2239. PubMed ID: 27427485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of senescence pathways in Kindler syndrome primary keratinocytes.
    Piccinni E; Di Zenzo G; Maurelli R; Dellambra E; Teson M; Has C; Zambruno G; Castiglia D
    Br J Dermatol; 2013 May; 168(5):1019-26. PubMed ID: 23278235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kindlin-1 Regulates Epidermal Growth Factor Receptor Signaling.
    Michael M; Begum R; Chan GK; Whitewood AJ; Matthews DR; Goult BT; McGrath JA; Parsons M
    J Invest Dermatol; 2019 Feb; 139(2):369-379. PubMed ID: 30248333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FERMT1 promoter mutations in patients with Kindler syndrome.
    Has C; Chmel N; Levati L; Neri I; Sonnenwald T; Pigors M; Godbole K; Dudhbhate A; Bruckner-Tuderman L; Zambruno G; Castiglia D
    Clin Genet; 2015 Sep; 88(3):248-54. PubMed ID: 25156791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Realm of revertant mosaicism expanding.
    Jonkman MF; Pasmooij AM
    J Invest Dermatol; 2012 Mar; 132(3 Pt 1):514-6. PubMed ID: 22327264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is adermatoglyphia an additional feature of Kindler Syndrome?
    Almeida HL; Goetze FM; Fong K; Lai-Cheong J; McGrath J
    An Bras Dermatol; 2015; 90(4):592-3. PubMed ID: 26375235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revertant mosaicism in Kindler syndrome.
    Lai-Cheong JE; Moss C; Parsons M; Almaani N; McGrath JA
    J Invest Dermatol; 2012 Mar; 132(3 Pt 1):730-2. PubMed ID: 22089829
    [No Abstract]   [Full Text] [Related]  

  • 11. Founder mutation c.676insC in three unrelated Kindler syndrome families belonging to a particular clan from Pakistan.
    Shaiq PA; Klausegger A; Muzaffar F; Bauer JW; Khan MI; Khanum A; Qamar R; Raja GK
    J Dermatol; 2012 Jul; 39(7):640-1. PubMed ID: 22220914
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel and recurrent FERMT1 gene mutations in Kindler syndrome.
    Techanukul T; Sethuraman G; Zlotogorski A; Horev L; Macarov M; Trainer A; Fong K; Lens M; Medenica L; Ramesh V; McGrath JA; Lai-Cheong JE
    Acta Derm Venereol; 2011 May; 91(3):267-70. PubMed ID: 21336475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of Kindler syndrome in a young Indian female with exon deletion.
    Fukushi R; Tsuboi R; Maeda T; Kanda Y; Sakai N; Suzuki S; Harada K
    Int J Dermatol; 2019 Jan; 58(1):e19-e21. PubMed ID: 30414177
    [No Abstract]   [Full Text] [Related]  

  • 14. Kindler syndrome: extension of FERMT1 mutational spectrum and natural history.
    Has C; Castiglia D; del Rio M; Diez MG; Piccinni E; Kiritsi D; Kohlhase J; Itin P; Martin L; Fischer J; Zambruno G; Bruckner-Tuderman L
    Hum Mutat; 2011 Nov; 32(11):1204-12. PubMed ID: 21936020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two novel mutations in KIND1 in Indian patients with Kindler syndrome.
    Kantheti P; Kubba A; Prabhu A; Batrani M; Hiremagalore R
    Clin Exp Dermatol; 2017 Jan; 42(1):95-97. PubMed ID: 27862150
    [No Abstract]   [Full Text] [Related]  

  • 16. Kindler syndrome: a focal adhesion genodermatosis.
    Lai-Cheong JE; Tanaka A; Hawche G; Emanuel P; Maari C; Taskesen M; Akdeniz S; Liu L; McGrath JA
    Br J Dermatol; 2009 Feb; 160(2):233-42. PubMed ID: 19120339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UV-B-induced cutaneous inflammation and prospects for antioxidant treatment in Kindler syndrome.
    Maier K; He Y; Wölfle U; Esser PR; Brummer T; Schempp C; Bruckner-Tuderman L; Has C
    Hum Mol Genet; 2016 Dec; 25(24):5339-5352. PubMed ID: 27798104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of Kindler syndrome and propensity for skin cancer - case report and literature review.
    Saleva M; Has C; He Y; Vassileva S; Balabanova M; Miteva L
    J Dtsch Dermatol Ges; 2018 Mar; 16(3):338-341. PubMed ID: 29384271
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression of exon-8-skipped kindlin-1 does not compensate for defects of Kindler syndrome.
    Natsuga K; Nishie W; Shinkuma S; Nakamura H; Matsushima Y; Tatsuta A; Komine M; Shimizu H
    J Dermatol Sci; 2011 Jan; 61(1):38-44. PubMed ID: 21146372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial loss of epithelial phenotype in kindlin-1-deficient keratinocytes.
    Qu H; Wen T; Pesch M; Aumailley M
    Am J Pathol; 2012 Apr; 180(4):1581-92. PubMed ID: 22326752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.